Jaguar Health (JAGX) EPS (Diluted) Growth (3y) (2023 - 2026)
Jaguar Health (JAGX) EPS (Diluted) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 37.28% |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 14.39% |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | -2.00% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 61.64% |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 45.22% |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 95.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.24% |
| Dec 31, 2025 | 89.53% |
| Sep 30, 2025 | 92.16% |
| Jun 30, 2025 | 90.80% |
| Mar 31, 2025 | 92.90% |
| Dec 31, 2024 | 90.22% |
| Sep 30, 2024 | 90.27% |
| Jun 30, 2024 | 85.97% |
| Mar 31, 2024 | 85.92% |
| Dec 31, 2023 | 82.33% |
| Sep 30, 2023 | 80.74% |
| Jun 30, 2023 | 83.95% |